- Current report filing (8-K)
September 14 2010 - 5:04AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
|
Date of Report (Date of Earliest Event Reported):
|
|
September 13, 2010
|
ThermoGenesis Corp.
__________________________________________
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
333-82900
|
94-3018487
|
_____________________
(State or other jurisdiction
|
_____________
(Commission
|
______________
(I.R.S. Employer
|
of incorporation)
|
File Number)
|
Identification No.)
|
|
|
|
2711 Citrus Rd., Rancho Cordova, California
|
|
95742
|
_________________________________
(Address of principal executive offices)
|
|
___________
(Zip Code)
|
|
|
|
Registrants telephone number, including area code:
|
|
916-858-5100
|
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On September 13, 2010, ThermoGenesis Corp. (the "Company") issued a press release announcing that it has received notice from the Nasdaq Stock Market ("Nasdaq") confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2).
A copy of the press release, dated September 13, 2010 is furnished as Exhibit 99.1 to this Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
99.1 Press release dated September 13, 2010, titled "ThermoGenesis Regains Compliance with Nasdaq Listing Rule".
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
|
|
|
|
|
ThermoGenesis Corp.
|
|
|
|
|
|
September 13, 2010
|
|
By:
|
|
Matthew T. Plavan
|
|
|
|
|
|
|
|
|
|
Name: Matthew T. Plavan
|
|
|
|
|
Title: CFO & EVP, Business Development
|
Exhibit Index
|
|
|
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
99.1 Press release dated September 13, 2010, titled "ThermoGenesis Regains Compliance with Nasdaq Listing Rule".
|
Cesca Therapeutics, Inc. (MM) (NASDAQ:KOOLD)
Historical Stock Chart
From May 2024 to Jun 2024
Cesca Therapeutics, Inc. (MM) (NASDAQ:KOOLD)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Cesca Therapeutics, Inc. (MM) (NASDAQ): 0 recent articles
More News Articles